Literature DB >> 22893718

Fetal insulin and IGF-II contribute to gestational diabetes mellitus (GDM)-associated up-regulation of membrane-type matrix metalloproteinase 1 (MT1-MMP) in the human feto-placental endothelium.

U Hiden1, L Lassance, N Ghaffari Tabrizi, H Miedl, C Tam-Amersdorfer, I Cetin, U Lang, G Desoye.   

Abstract

CONTEXT: Gestational diabetes mellitus (GDM)-associated hormonal and metabolic derangements in mother and fetus affect placental development and function. Indeed, in GDM, placentas are characterized by hypervascularization and vascular dysfunction. The membrane-type matrix metalloproteinase 1 (MT1-MMP) is a key player in angiogenesis and vascular expansion.
OBJECTIVE: Here, we hypothesized elevated placental MT1-MMP levels in GDM induced by components of the diabetic environment. Therefore, we measured placental MT1-MMP in normal vs. GDM pregnancies, identified potential functional consequences, and investigated the contribution of hyperglycemia and the insulin/IGF axis.
DESIGN: Immunohistochemistry identified placental cell types expressing MT1-MMP. MT1-MMP was compared between normal and GDM placentas by immunoblotting. Quantitative PCR of MT1-MMP in primary feto-placental endothelial cells (fpEC) and trophoblasts isolated from both normal and GDM placentas identified the cells contributing to the GDM-associated changes. A putative MT1-MMP role in angiogenesis was determined using blocking antibodies for in vitro angiogenesis assays. Potential GDM-associated factors and signaling pathways inducing MT1-MMP up-regulation in fpEC were identified using kinase inhibitors.
RESULTS: Total and active MT1-MMP was increased in GDM placentas (+51 and 54%, respectively, P<0.05) as a result of up-regulated expression in fpEC (2.1-fold, P=0.02). MT1-MMP blocking antibodies reduced in vitro angiogenesis up to 25% (P=0.03). Pathophysiological levels of insulin and IGF-II, but not IGF-I and glucose, stimulated MT1-MMP expression in fpEC by phosphatidylinositol 3-kinase signals relayed through the insulin, but not IGF-I, receptor.
CONCLUSIONS: GDM up-regulates MT1-MMP in the feto-placental endothelium, and insulin and IGF-II contribute. This may account for GDM-associated changes in the feto-placental vasculature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893718     DOI: 10.1210/jc.2012-1212

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Placental membrane-type metalloproteinases (MT-MMPs): Key players in pregnancy.

Authors:  Alejandro Majali-Martinez; Ursula Hiden; Nassim Ghaffari-Tabrizi-Wizsy; Uwe Lang; Gernot Desoye; Martina Dieber-Rotheneder
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

2.  Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM.

Authors:  Francisca Isidora Díaz-Pérez; Ursula Hiden; Martin Gauster; Ingrid Lang; Viktoria Konya; Akos Heinemann; Jelena Lögl; Richard Saffery; Gernot Desoye; Silvija Cvitic
Journal:  Cell Adh Migr       Date:  2016-01-13       Impact factor: 3.405

3.  Gestational diabetes mellitus upregulates vitamin D receptor in extravillous trophoblasts and fetoplacental endothelial cells.

Authors:  Julia Knabl; Rebecca Hüttenbrenner; Stefan Hutter; Maria Günthner-Biller; Christina Riedel; Ursula Hiden; Franz Kainer; Gernot Desoye; Udo Jeschke
Journal:  Reprod Sci       Date:  2014-07-15       Impact factor: 3.060

Review 4.  Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity.

Authors:  Gernot Desoye; Anthony M Carter
Journal:  Nat Rev Endocrinol       Date:  2022-07-28       Impact factor: 47.564

5.  Interleukin-1β inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts.

Authors:  Irving L M H Aye; Thomas Jansson; Theresa L Powell
Journal:  Mol Cell Endocrinol       Date:  2013-07-25       Impact factor: 4.102

6.  Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling.

Authors:  Kristoffer B Sugg; James F Markworth; Nathaniel P Disser; Andrew M Rizzi; Jeffrey R Talarek; Dylan C Sarver; Susan V Brooks; Christopher L Mendias
Journal:  Am J Physiol Cell Physiol       Date:  2017-12-13       Impact factor: 4.249

Review 7.  Glucose, insulin, and oxygen interplay in placental hypervascularisation in diabetes mellitus.

Authors:  Silvija Cvitic; Gernot Desoye; Ursula Hiden
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

8.  Slow fetal growth between first and early second trimester ultrasound scans and risk of small for gestational age (SGA) birth.

Authors:  Marija Simic; Olof Stephansson; Gunnar Petersson; Sven Cnattingius; Anna-Karin Wikström
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

9.  Increased endothelial inflammation, sTie-2 and arginase activity in umbilical cords obtained from gestational diabetic mothers.

Authors:  Hemant Giri; Shivam Chandel; Linga S Dwarakanath; Sooriyakala Sreekumar; Madhulika Dixit
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 10.  Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus.

Authors:  Luis Sobrevia; Rocío Salsoso; Bárbara Fuenzalida; Eric Barros; Lilian Toledo; Luis Silva; Carolina Pizarro; Mario Subiabre; Roberto Villalobos; Joaquín Araos; Fernando Toledo; Marcelo González; Jaime Gutiérrez; Marcelo Farías; Delia I Chiarello; Fabián Pardo; Andrea Leiva
Journal:  Front Physiol       Date:  2016-03-31       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.